BioAge Labs Director Pande Vijay Satyanand Buys $16.2m in Stock

Investing16:32 ET

Bioage Labs Insider Bought Shares Worth $11,999,970, According to a Recent SEC Filing

MT Newswires16:29 ET

Biotech IPOs Return as Sector Recovers After Funding Overhang

Seeking Alpha14:49 ET

BioAge, BKV Shares End Their First Trading Day Flat After Earlier Gains

MarketWatchSep 26 16:35 ET

BioAge Posts Double-digit Percentage Gain After IPO; Natural-gas Producer BKV Rises in Debut

MarketWatchSep 26 12:50 ET

BioAge Labs Shares Surge on Nasdaq Debut

MT NewswiresSep 26 12:40 ET